Yüklüyor......
suPAR and Team Nephrology
Primary focal segmental glomerulosclerosis (FSGS) accounts for nearly 10 % of patients who require renal replacement therapy. Elevated circulating levels of soluble urokinase receptor (suPAR) have been identified as a biomarker to discriminate primary FSGS from other glomerulopathies. Subsequent rep...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4026824/ https://ncbi.nlm.nih.gov/pubmed/24885021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-12-82 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|